Literature DB >> 31108056

Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures.

Sonia Labrador-Velandia1, Maria Luz Alonso-Alonso1, Salvatore Di Lauro2, Maria Teresa García-Gutierrez1, Girish K Srivastava3, José Carlos Pastor4, Ivan Fernandez-Bueno5.   

Abstract

Through the paracrine effects of stem cells, including the secretion of neurotrophic, immunomodulatory, and anti-apoptotic factors, cell-based therapies offer a new all-encompassing approach to treatment of neurodegenerative diseases. In this study, we used physically separated co-cultures of porcine neuroretina (NR) and human mesenchymal stem cells (MSC) to evaluate the MSC paracrine neuroprotective effects on NR degeneration. NR explants were obtained from porcine eyes and cultured alone or co-cultured with commercially available MSCs from Valladolid (MSCV; Citospin S.L.; Valladolid, Spain), currently used for several approved treatments. Cultures were maintained for 72 h. MSC surface markers were evaluated before and after co-culture with NRs. Culture supernatants were collected and the concentration of brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), and glial-derived neurotrophic factor (GDNF) were determined by enzyme-linked immunosorbent assays. NR sections were stained by haematoxylin/eosin or immunostained for terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL), glial fibrillary acidic protein, β-tubulin III, and neuronal nuclei marker. NR morphology, morphometry, nuclei count, apoptosis rate, retinal ganglion cells, and glial cell activation were evaluated. Treatment effects were statistically analysed by parametric or non-parametric tests. The MSCs retained stem cell surface markers after co-culture with NR. BDNF and CNTF concentrations in NR-MSCV co-cultures were higher than other experimental conditions at 72 h (p < 0.05), but no GDNF was detected. NR general morphology, total thickness, and cell counts were broadly preserved in co-cultures, and the apoptosis rate determined by TUNEL assay was lower than for NR monocultures (all p < 0.05). Co-cultures with MSCV also protected retinal ganglion cells from degenerative changes and reduced reactive gliosis (both p < 0.05). In this in vitro model of spontaneous NR degeneration, the presence of co-cultured MSCs retarded neuroglial degeneration. This effect was associated with elevated concentrations of the neurotrophic factors BDNF and CNTF. Our data suggest that the paracrine secretion of these, and possibly other molecules, are a potential resource for the treatment of several neuroretinal diseases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mesenchymal stem cell (MSC); Neuroretinal culture; Neurotrophic factors; Paracrine properties; Retinal ganglion cell (RGC)

Mesh:

Substances:

Year:  2019        PMID: 31108056     DOI: 10.1016/j.exer.2019.05.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  16 in total

1.  Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells' Paracrine Properties.

Authors:  Ivan Fernandez-Bueno; Ricardo Usategui-Martin
Journal:  Methods Mol Biol       Date:  2021

2.  Therapeutic effect of the mesenchymal stem cells on vigabatrin-induced retinopathy in adult male albino rat.

Authors:  Ayat Mahmoud Domouky; Walaa M Samy; Walaa A Rashad
Journal:  Anat Cell Biol       Date:  2022-06-30

3.  The Chemokine Receptors Ccr5 and Cxcr6 Enhance Migration of Mesenchymal Stem Cells into the Degenerating Retina.

Authors:  Martina Pesaresi; Sergi A Bonilla-Pons; Ruben Sebastian-Perez; Umberto Di Vicino; Marc Alcoverro-Bertran; Ralph Michael; Maria Pia Cosma
Journal:  Mol Ther       Date:  2020-12-01       Impact factor: 11.454

Review 4.  Interaction Between Mesenchymal Stem Cells and Retinal Degenerative Microenvironment.

Authors:  Yu Lin; Xiang Ren; Yongjiang Chen; Danian Chen
Journal:  Front Neurosci       Date:  2021-01-21       Impact factor: 4.677

5.  Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model.

Authors:  Sally L Elshaer; Hang-Soo Park; Laura Pearson; William D Hill; Frank M Longo; Azza B El-Remessy
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 6.  Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases.

Authors:  Sally L Elshaer; Salma H Bahram; Pranav Rajashekar; Rajashekhar Gangaraju; Azza B El-Remessy
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

Review 7.  Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges.

Authors:  Rosa M Coco-Martin; Salvador Pastor-Idoate; Jose Carlos Pastor
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

8.  Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration.

Authors:  Ricardo Usategui-Martín; Kevin Puertas-Neyra; María-Teresa García-Gutiérrez; Manuel Fuentes; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-13       Impact factor: 6.698

Review 9.  Coculture techniques for modeling retinal development and disease, and enabling regenerative medicine.

Authors:  Ali E Ghareeb; Majlinda Lako; David H Steel
Journal:  Stem Cells Transl Med       Date:  2020-08-07       Impact factor: 6.940

10.  Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome.

Authors:  Ricardo Usategui-Martin; Ivan Fernandez-Bueno
Journal:  Neural Regen Res       Date:  2021-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.